Yatiri Bio Accurately Predicts AML Drug Response in Blinded Study Using Foghorn’s FHD

SAN DIEGO, Feb. 10, 2026 (GLOBE NEWSWIRE) — A demonstrated 100% concordance between biomarker-guided predictions from pre-treatment patient samples and clinical outcomes validates Yatiri Bio’s platform as a breakthrough in oncology patient stratification. Yatiri Bio, a precision medicine company utilizing an AI-driven proteomic platform (ProteoCharts™) to identify therapeutically sensitive patient populations, reports results from a […]


4 w.
Science
ID: 6290116810112678573


Similar News expand_more


Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Technology
Science
Science
Science
Science
Science
Space
Science
Technology
Science
Science
Technology
Science
Science
Education
Science
Science
Technology
Science
Technology
Crime
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Travel
Technology
Science
Entertainment
Politics
Science
Add Watch Country

arrow_drop_down